| 000 | 01367 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517003929.0 | ||
| 264 | 0 | _c20150130 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1565-1088 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarzi-Puttini, Piercarlo | |
| 245 | 0 | 0 |
_aNew biological treatments for psoriatic arthritis. _h[electronic resource] |
| 260 |
_bThe Israel Medical Association journal : IMAJ _cOct 2014 |
||
| 300 |
_a643-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xclassification |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xclassification |
| 650 | 0 | 4 |
_aInterleukin-17 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 650 | 0 | 4 | _aTumor Necrosis Factor Inhibitors |
| 650 | 0 | 4 | _aUstekinumab |
| 700 | 1 | _aAtzeni, Fabiola | |
| 773 | 0 |
_tThe Israel Medical Association journal : IMAJ _gvol. 16 _gno. 10 _gp. 643-5 |
|
| 999 |
_c24393509 _d24393509 |
||